Vimarsana
Biggest News Aggregation in the World

Page 13 - Trials Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Unit Today - Breaking & Trending Today

Easy-to-take medicine better at suppressing HIV in children - Vimarsana News

Easy-to-take medicine better at suppressing HIV in children

A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments,

Study focuses on inherited Alzheimer's up to 25 years before expected dementia onset - Vimarsana News

Study focuses on inherited Alzheimer's up to 25 years before expected dementia onset

Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer's disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer's prevention trials, this one will enroll people before the disease has taken hold - up to 25 years before the expected onset of dementia.

New Alzheimer's prevention trial in young people - Vimarsana News

New Alzheimer's prevention trial in young people

Neurologist Eric McDade, DO, meets with Marty Reiswig, a participant in Alzheimer’s prevention trials at Washington University School of Medicine in

Annual Faculty Synergy Research Event celebrates collaboration and achievements - Vimarsana News

Annual Faculty Synergy Research Event celebrates collaboration and achievements

Sharing ideas that facilitate the discovery of answers to important questions can be an essential part of scientific research. On Tuesday, Dec.

Source: tulane.edu
New Alzheimer's prevention trial in young people - The Source - Washington University in St. Louis - Vimarsana News

New Alzheimer's prevention trial in young people - The Source - Washington University in St. Louis

Researchers at Washington University School of Medicine are conducting an Alzheimer's prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.

Source: wustl.edu